MedPath

The effectiveness and underlying mechanisms of eye movement desensitisation and reprocessing (EMDR) for posttraumatic stress disorder in Timor Leste.

Not Applicable
Completed
Conditions
Posttraumatic stress disorder
Mental Health - Anxiety
Registration Number
ACTRN12611000239965
Lead Sponsor
Murdoch University - School of Psychology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

(1) Exposure to traumatic events in Timor Leste.
(2) The traumatic event occured at least 3 months prior to study entry.
(3) Has symptoms consistent with PTSD.
(4) Timorese resident.
(5) Males and females.
(6) Willingness to participate in the study (informed consent procedure).
(7) The participant has a level of stability and support or is linked with a Timorese NGO health service.

Exclusion Criteria

(1) Deaf, Blind, or a history of serious eye disease.
(2) The participant is in an ongoing threatening situation.
(3) Suicidal intent.
(4) Problematic substance use.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptoms consistent with PTSD is measured with the Harvard Trauma Questionnaire (HTQ: a version translated to Tetun/Indonesian).[Administered at 2 weeks pre-treatment, pre-treatment, 2 weeks post-treatment, and at 3-months post-treatment.]
Secondary Outcome Measures
NameTimeMethod
Depression is measured by using the Hopkins Symptom Checklist (HSCL - 25)[Administered at 2 weeks pre-treatment, pre-treatment, 2 weeks post-treatment, and at 3-months post-treatment.];Anxiety, symptoms of general anxiety is measured by using the Hopkins Symptom Checklist (HSCL - 25).[Administered at 2 weeks pre-treatment, pre-treatment, 2 weeks post-treatment, and at 3-months post-treatment.];The distress related to the memory of the event targeted for processing is measured by the within session process measure of Subject Units of distress (SUDS).[Administered during all desensitisation sessions, 2 weeks post treatment, and at 3-months post-treatment.];Psychophysiological changes within session and across treatment.[Within the first and last active treatment session ongoing measures of heart rate (HR), heart rate variability (HRV), skin conductance (SC), and respiration rate (RR) will be recorded.]
© Copyright 2025. All Rights Reserved by MedPath